US › Healthcare

AstraZeneca PLC (AZN)

US · Healthcare · Drug Manufacturers - General

$166.14+2.00%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$15.38B

Revenue YoY

+6.4%

Net profit

$2.51B

Profit YoY

+2.3%

EPS

$2.63

EPS estimate

$2.50

Net margin

16.3%

EPS came in at 2.63 against a street estimate of 2.50 — a beat of 5.2%.

Key statistics

Market cap

$248.41B

P/E

24.0

Forward P/E

13.9

P/B

4.94

Book value

$32.43

EPS (TTM)

$6.68

Dividend yield

2.02%

52-week high

$209.11

52-week low

$143.33

50-day MA

$166.78

200-day MA

$183.49

Beta

0.20

Analyst view

Analysts rate AstraZeneca PLC a strong buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $212.90.

Shareholding

Insiders

0.05%

Institutions

64.95%

Largest institutional holders

Fund	Stake
Investors Finance Co PLC	3.33%
Vanguard Capital Management, LLC	2.90%
Capital Research & Mgmt Co - Division 3	2.23%
NORGES BANK	2.18%
Capital World Investors	1.94%
FMR Inc	1.91%
Wellington Management Company LLP	1.84%
Legal & General Group PLC	1.67%

Corporate actions

Action	Detail	Date
Dividend	$1.06 / share ex-date Aug 7, 2026 · pay Sep 8, 2026	2026-08-07
Dividend	$2.17 / share ex-date Feb 20, 2026 · pay Mar 23, 2026	2026-02-20
Split	1 : 2 effective Feb 2, 2026	2026-02-02

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for AstraZeneca PLC — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories Pfizer Inc

Data updated 2026-09-18.